Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF DERMATOLOGY   FALL 2007 , Volume 10 , Number 3 (41); Page(s) 240 To 244.
 
Paper: 

COMPLETE RESOLUTION OF CHRONIC CUTANEOUS LEISHMANIASIS BY COMBINATION THERAPY WITH SYSTEMIC GLUCANTIME, ORAL FLUCONAZOLE AND 50% TRICHLOROACETIC ACID SOLUTION: REPORT OF ONE CASE

 
 
Author(s):  NILFOROUSHZADEH MOHAMMAD ALI*, HAFT BARADARAN E., SIADAT A.H.
 
* SKIN DISEASE AND LEISHMANIASIS RESEARCH CENTER, KHORAM ST., SEDIGH TAHEREH RESEARCH CENTERS, ISFAHAN, IRAN
 
Abstract: 

Cutaneous leishmaniasis is an endemic disease in Iran and there is no curative treatment. The disfiguring scar that remains after it subsidesis a major psychologic and emotional problem in these patients. Chronic leishmaniasisis a rare form of this malady which is seen in 5-7 percent of cases. In this article we report a 46-year-old man who was refered to us for a large leishmaniasis lesion consisting of a scaling erythematous plaque with several papules on the right side of face and nose. This patient was treated by a combination of systemic Glucantime, 50% trichlroacetic acid and oral fluconazole. Complete resolution was achieved after 4 months.

 
Keyword(s): CUTANEOUS LEISHMANIASIS, GLUCANTIME, ORAL FLUCONZOLE, TRICHLOROACETIC ACID
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 83
 
Latest on Blog
Enter SID Blog